The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis

H An; E Y P Lee; K Chiu; C Chang

doi:10.1016/j.crad.2018.03.009

The emerging roles of functional imaging in ovarian cancer with peritoneal carcinomatosis

Clin Radiol. 2018 Jul;73(7):597-609. doi: 10.1016/j.crad.2018.03.009. Epub 2018 Apr 21.

Authors

H An¹, E Y P Lee², K Chiu¹, C Chang¹

Affiliations

¹ Department of Diagnostic Radiology, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region.
² Department of Diagnostic Radiology, Queen Mary Hospital, University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: [email protected].

PMID: 29685803
DOI: 10.1016/j.crad.2018.03.009

Abstract

This article reviews the emerging roles of functional imaging in the assessment of peritoneal carcinomatosis in ovarian cancer, focusing on the use of diffusion-weighted magnetic resonance imaging (DW-MRI) and 2-[¹⁸F]-fluoro-2-deoxy-d-glucose positron-emission tomography combined with computed tomography (PET-CT), their advantages and shortcomings as well as the added-value over conventional imaging.

Publication types

Review

MeSH terms

Diffusion Magnetic Resonance Imaging / methods*
Female
Fluorodeoxyglucose F18
Humans
Ovarian Neoplasms / complications*
Ovarian Neoplasms / diagnostic imaging*
Ovary / diagnostic imaging
Peritoneal Neoplasms / complications*
Peritoneal Neoplasms / diagnostic imaging*
Peritoneum / diagnostic imaging
Positron Emission Tomography Computed Tomography / methods*
Radiopharmaceuticals
Sensitivity and Specificity

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18